Brain tumor, breast cancer, colon cancer, congenital heart disease, heart arrhythmia. See more conditions.
Stephen M. Ansell, M.D., Ph.D., is a hematologist and oncologist who also conducts cancer research. Dr. Ansell studies the biology of B cell cancers, including Hodgkin's lymphoma, Waldenstrom macroglobulinemia and non-Hodgkin's lymphoma. Dr. Ansell also investigates the role of the tumor microenvironment in supporting cancer cell growth and survival.
Dr. Ansell's goal is to translate knowledge gained from his research into new treatment approaches. Dr. Ansell's research contributed to the use of immune checkpoint therapy in lymphomas. In addition, Dr. Ansell led the clinical trial that resulted in the approval by the U.S. Food and Drug Administration (FDA) of nivolumab (Opdivo) for Hodgkin's lymphoma.
Learn about clinical trials that address specific scientific questions about human health and disease.
See my studies.
Explore all research studies at Mayo Clinic.
See the peer-reviewed findings I have published as a result of my research.
Review my research fingerprint, network, grants, projects, publications, Scopus profile, and Altmetrics scores and badges.
Mayo Clinic is a nonprofit organization and proceeds from Web advertising help support our mission. Mayo Clinic does not endorse any of the third party products and services advertised.
A single copy of these materials may be reprinted for noncommercial personal use only. "Mayo," "Mayo Clinic," "MayoClinic.org," "Mayo Clinic Healthy Living," and the triple-shield Mayo Clinic logo are trademarks of Mayo Foundation for Medical Education and Research.